Zydus to expand vaccine capacity

The company has invested ₹250-350 crore so far on trials of the vaccine and its manufacturing.Zydus Cadila expects to submit to the drug regulator its safety and efficacy data for the vaccine in either April or June

from mint - News https://ift.tt/3pLF6V6
https://ift.tt/eA8V8J